Determinants and Correlates of Physical Activity in Breast Cancer Survivors

乳腺癌幸存者身体活动的决定因素和相关性

基本信息

项目摘要

DESCRIPTION (provided by applicant): There are over 2.4 million breast cancer survivors (BCS) in the U.S. accounting for 22% of all cancer survivors [1]. The 5-year survival rate of 88.6% [1] coupled with a 1 in 8 lifetime chance of a breast cancer diagnosis [2] has resulted in an increasingly growing population with distinct public health needs resulting from side effects associated with current available treatments [3]. In addition, BCS are at an increased risk of cancer recurrence, comborbidites, premature death and decreased quality of life (QOL) [4-6]. Physical activity (PA) has been identified as a lifestyle factor with excellent potential for ameliorating the aversive side effects of treatment and positively influencing disease-related outcomes [7, 8]. However, only 1/3 of BCS meet the current public health guidelines for PA [9, 10]. Identifying factors influencing PA participation and how PA is related to QOL in BCS is important for developing effective interventions which can be translated into practice. This project will adopt a prospective design to test the full Social Cognitive Theory (SCT) model for explaining PA in BCS over the course of a 6-month period. Previous research has used individual elements of SCT to understand and predict PA behavior in the general population [11-13], but the full model has yet to be tested, particularly in BCS. The proposed study will include measures to test the full SCT: self-efficacy, goals, outcome expectations, sociocultural factors (facilitators and impediments), and PA behavior [14]. PA has also been shown to positively influence QOL in BCS [7, 8]. However, very little research has been conducted to explain this relationship. Thus, the proposed study will also include measures to test the PA and QOL model proposed by McAuley and colleagues [15] in BCS. This model proposes PA influences global QOL indirectly through its effects on self-efficacy and health related QOL (physical and mental health) whereby self-efficacy is both directly and indirectly related to global QOL through its effect on health related QOL. The public health significance of this study lies in its potential to develop an improved, theoretically sound understanding of PA behavior in BCS as well as a better understanding of the relationship between PA and QOL. These findings could potentially result in better designed, more effective PA programs for BCS which ultimately has the potential to reduce healthcare costs associated with cancer recurrence, comorbidities, and premature death in BCS.
描述(由申请人提供):美国有超过240万乳腺癌幸存者(BCS),占所有癌症幸存者的22%[1]。88.6%的5年生存率[1]加上1/8的终身乳腺癌诊断机会[2]导致人口日益增长,由于与当前可用治疗相关的副作用而产生不同的公共卫生需求[3]。此外,BCS的癌症复发、合并症、过早死亡和生活质量(QOL)下降的风险增加[4-6]。 体力活动(PA)已被确定为一种生活方式因素,具有改善治疗不良副作用和积极影响疾病相关结局的良好潜力[7,8]。然而,只有1/3的BCS符合PA的现行公共卫生指南[9,10]。识别影响PA参与的因素以及PA与BCS中的QOL如何相关对于制定可以转化为实践的有效干预措施非常重要。 本研究将采用前瞻性的设计,在六个月的时间内测试社会认知理论(SCT)解释BCS中PA的完整模型。以前的研究已经使用SCT的单个元素来理解和预测一般人群中的PA行为[11-13],但完整的模型尚未得到测试,特别是在BCS中。拟议的研究将包括测试完整SCT的措施:自我效能,目标,结果预期,社会文化因素(促进者和障碍)和PA行为[14]。 PA也被证明对BCS的QOL有积极影响[7,8]。然而,很少有研究来解释这种关系。因此,拟议的研究还将包括测试McAuley及其同事[15]在BCS中提出的PA和QOL模型的措施。该模型提出PA通过影响自我效能和健康相关QOL(身体和心理健康)间接影响整体QOL,其中自我效能通过影响健康相关QOL直接或间接影响整体QOL。 本研究的公共卫生意义在于它有可能发展一个改进的,理论上合理的理解,在BCS的PA行为,以及更好地了解PA和生活质量之间的关系。这些发现可能会导致更好的设计,更有效的PA计划,最终有可能降低与BCS癌症复发,合并症和过早死亡相关的医疗费用。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Siobhan Marie Phillips其他文献

Siobhan Marie Phillips的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Siobhan Marie Phillips', 18)}}的其他基金

Research and Methods Core
研究和方法核心
  • 批准号:
    10895116
  • 财政年份:
    2022
  • 资助金额:
    $ 3.56万
  • 项目类别:
Research and Methods Core
研究和方法核心
  • 批准号:
    10682522
  • 财政年份:
    2022
  • 资助金额:
    $ 3.56万
  • 项目类别:
Fit2ThriveMIND: Optimizing a mHealth Physical Activity Intervention with Mindful Awareness Lessons in Breast Cancer Survivors
Fit2ThriveMIND:通过乳腺癌幸存者的正念意识课程优化移动健康身体活动干预
  • 批准号:
    10684754
  • 财政年份:
    2022
  • 资助金额:
    $ 3.56万
  • 项目类别:
Fit2ThriveMIND: Optimizing a mHealth Physical Activity Intervention with Mindful Awareness Lessons in Breast Cancer Survivors
Fit2ThriveMIND:通过乳腺癌幸存者的正念意识课程优化移动健康身体活动干预
  • 批准号:
    10539045
  • 财政年份:
    2022
  • 资助金额:
    $ 3.56万
  • 项目类别:
Research and Methods Core
研究和方法核心
  • 批准号:
    10454617
  • 财政年份:
    2022
  • 资助金额:
    $ 3.56万
  • 项目类别:
Optimization of a mHealth Physical Activity Promotion Intervention with Mindful Awareness for Adolescent and Young Adult Cancer Survivors
优化青少年和年轻癌症幸存者的 mHealth 身体活动促进干预措施和正念意识
  • 批准号:
    10278744
  • 财政年份:
    2021
  • 资助金额:
    $ 3.56万
  • 项目类别:
Advancing Understanding and Implementation of Digital Mindfulness Applications in Colombian Cancer Care
促进哥伦比亚癌症护理中数字正念应用的理解和实施
  • 批准号:
    10622777
  • 财政年份:
    2021
  • 资助金额:
    $ 3.56万
  • 项目类别:
Optimization of a mHealth Physical Activity Promotion Intervention with Mindful Awareness for Adolescent and Young Adult Cancer Survivors
优化青少年和年轻癌症幸存者的 mHealth 身体活动促进干预措施和正念意识
  • 批准号:
    10679048
  • 财政年份:
    2021
  • 资助金额:
    $ 3.56万
  • 项目类别:
Multi-site adaptive trial of a technology-based, EHR-integrated physical activity intervention in breast and endometrial cancer survivors
对乳腺癌和子宫内膜癌幸存者进行基于技术、电子病历整合的体力活动干预的多地点适应性试验
  • 批准号:
    10560624
  • 财政年份:
    2019
  • 资助金额:
    $ 3.56万
  • 项目类别:
Designing with Dissemination in Mind: Optimization of a mHealth Physical Activity Intervention for Breast Cancer Survivors
设计时考虑到传播:优化乳腺癌幸存者的移动健康身体活动干预措施
  • 批准号:
    9133330
  • 财政年份:
    2015
  • 资助金额:
    $ 3.56万
  • 项目类别:

相似海外基金

Countering sympathetic vasoconstriction during skeletal muscle exercise as an adjuvant therapy for DMD
骨骼肌运动期间对抗交感血管收缩作为 DMD 的辅助治疗
  • 批准号:
    10735090
  • 财政年份:
    2023
  • 资助金额:
    $ 3.56万
  • 项目类别:
The ESCAPE clinical trial of circulating tumor DNA to guide adjuvant therapy in chemo-resistant triple negative breast cancer
循环肿瘤 DNA 指导化疗耐药三阴性乳腺癌辅助治疗的 ESCAPE 临床试验
  • 批准号:
    494901
  • 财政年份:
    2023
  • 资助金额:
    $ 3.56万
  • 项目类别:
    Operating Grants
A Type I Hybrid Effectiveness-Implementation Trial to Evaluate a Navigation-Based Multilevel Intervention to Decrease Delays Starting Adjuvant Therapy Among Patients with Head and Neck Cancer
一项 I 型混合有效性实施试验,用于评估基于导航的多级干预措施,以减少头颈癌患者开始辅助治疗的延迟
  • 批准号:
    10714537
  • 财政年份:
    2023
  • 资助金额:
    $ 3.56万
  • 项目类别:
Multi-modal machine learning to guide adjuvant therapy in surgically resectable colorectal cancer
多模式机器学习指导可手术切除结直肠癌的辅助治疗
  • 批准号:
    10588103
  • 财政年份:
    2023
  • 资助金额:
    $ 3.56万
  • 项目类别:
Efficacy of ethanol adjuvant therapy after resection of malignant soft tissue tumors
恶性软组织肿瘤切除术后乙醇辅助治疗的疗效
  • 批准号:
    22K09407
  • 财政年份:
    2022
  • 资助金额:
    $ 3.56万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Identification of immune response cells and development of novel adjuvant therapy for sublingual immunotherapy
免疫应答细胞的鉴定和舌下免疫治疗新型辅助疗法的开发
  • 批准号:
    21KK0287
  • 财政年份:
    2022
  • 资助金额:
    $ 3.56万
  • 项目类别:
    Fund for the Promotion of Joint International Research (Fostering Joint International Research (A))
Pursuing molecular biomarkers to guide adjuvant therapy for HPV+ head and neck cancers after transoral robotic surgery
寻找分子生物标志物来指导经口机器人手术后 HPV 头颈癌的辅助治疗
  • 批准号:
    10357120
  • 财政年份:
    2022
  • 资助金额:
    $ 3.56万
  • 项目类别:
Biomarker research using two prospective studies on preoperative and postoperative adjuvant therapy for pancreatic cancer
使用两项关于胰腺癌术前和术后辅助治疗的前瞻性研究进行生物标志物研究
  • 批准号:
    21K08700
  • 财政年份:
    2021
  • 资助金额:
    $ 3.56万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Personalized Resistant Starch as an Adjuvant Therapy for Pediatric Inflammatory Bowel Disease
个性化抗性淀粉作为小儿炎症性肠病的辅助治疗
  • 批准号:
    437315
  • 财政年份:
    2020
  • 资助金额:
    $ 3.56万
  • 项目类别:
    Studentship Programs
Tailored adjuvant therapy in POLE-mutated and p53-wildtype early stage endometrial cancer (TAPER)
POLE 突变和 p53 野生型早期子宫内膜癌 (TAPER) 的定制辅助治疗
  • 批准号:
    435603
  • 财政年份:
    2020
  • 资助金额:
    $ 3.56万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了